Market Place
Sourcing Support
HDT Bio To Spearhead RNA Vaccine Development For Pandemic Preparedness
17 Sep 2024 //
PR NEWSWIRE
HDT Bio Publishes Peer-Reviewed Article On Enterovirus D68 Vaccine
07 Aug 2024 //
PR NEWSWIRE
Emcure, Gennova settle litigation with HDT, ink pact to develop mRNAvaccines
23 May 2024 //
MONEYCONROL
HDT Bio Receives $749,000 EZBAA Contract
23 Jan 2024 //
PR NEWSWIRE
HDT Bio Publishes Study Demonstrating Advantages of repRNA and LION Tech
24 Jul 2023 //
PR NEWSWIRE
HDT Bio Publishes Study Demonstrating Robust Immunological Response
24 Mar 2023 //
PR NEWSWIRE
HDT Bio Selected to Join BLUE KNIGHT™
07 Nov 2022 //
BUSINESSWIRE
HDT Bio’s COVID-19 Vaccine Wins Regulatory Approval in India
29 Jun 2022 //
BUSINESSWIRE
Emcure seeks to toss billion-dollar lawsuit over Covid vaccine candidate
17 May 2022 //
ENDPTS
HDT Bio Demonstrates RNA Vaccines Matched to SARS-CoV2 Variants Protection
05 Apr 2022 //
BUSINESSWIRE
US firm sues Emcure for $950 million over `stealing` trade secrets
23 Mar 2022 //
TIMESOFINDIA
SENAI CIMATEC Doses Healthy Volunteers in Phase 1 trial RNA COVID-19 Vaccine
17 Jan 2022 //
BUSINESSWIRE
Quratis Doses First Healthy Volunteers in Phase 1 Trial of RNA COVID-19 Vaccine
13 Dec 2021 //
BUSINESSWIRE
HDT Bio and SENAI CIMATEC get approval to trial Covid-19 vaccine in Brazil
31 Aug 2021 //
CLINICAL TRAIL ARENA
HDT Bio Announces Agreement With Korea’s Quratis
16 Aug 2021 //
BUSINESSWIRE
HDT Bio, Quratis to co-develop innovative COVID-19 vaccine in Asia
16 Aug 2021 //
BIOSPECTRUMASIA
HDT Bio Gets Notice to Proceed from FDA for Phase 1 Trial of RNA COVID-19 Jab
01 Jul 2021 //
BUSINESSWIRE
HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India
05 May 2021 //
PHARMACEUTICAL-TECHNOLOGY
HDT Bio Announces Completion of Seed Financing Round
05 Oct 2020 //
HDT
HDT BIO Receives NIH Contract to Advance Novel RNA/LION™ COVID-19 Vaccine
01 Sep 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.